Protara Therapeutics, Inc. - Common Stock (TARA)

Historical Holders from Q2 2020 to Q3 2025

Symbol
TARA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
38.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
26.2M
Holdings value
$114M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
79
Number of buys
36
Number of sells
-33
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Protara Therapeutics, Inc. - Common Stock (TARA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 11% +3.64% $18.4M $560K 4.23M +3.14% JANUS HENDERSON GROUP PLC 30 Sep 2025
BlackRock, Inc. 5.6% $6.39M 2.14M BlackRock, Inc. 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 4.9% -50% $5.97M -$4.42M 1.97M -42.5% RA Capital Management, L.P. 30 Jun 2025
Opaleye Management Inc. 4.71% -12.2% $7.47M -$410K 1.73M -5.21% Opaleye Management, Inc. 31 Mar 2025
CITADEL ADVISORS LLC 4.7% $7.03M 1.63M Kenneth Griffin 31 Dec 2024
Woodline Partners LP 3.9% $5.75M 1.33M Woodline Partners LP 31 Dec 2024

Institutional Holders of Protara Therapeutics, Inc. - Common Stock (TARA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 26.2M $114M -$10.4M $4.35 79
2025 Q2 29.7M $90.1M +$448K $3.03 76
2025 Q1 28.8M $124M -$8.35M $4.26 59
2024 Q4 29.7M $157M +$91.8M $5.28 60
2024 Q3 10.4M $19.1M +$384K $1.83 33
2024 Q2 10.4M $22.2M +$12M $2.08 38
2024 Q1 4.57M $18.3M +$911K $4.01 34
2023 Q4 4.36M $8.17M -$1.26M $1.88 30
2023 Q3 5.12M $8.55M -$31.8K $1.67 31
2023 Q2 5.14M $12.3M -$1.13M $2.39 28
2023 Q1 5.5M $16.9M +$77.6K $3.13 28
2022 Q4 5.48M $14.7M -$481K $2.68 29
2022 Q3 5.66M $16.7M -$789K $2.96 26
2022 Q2 5.93M $18.4M -$2.06M $2.93 31
2022 Q1 6.5M $33.2M -$1.99M $5.11 34
2021 Q4 6.87M $46.5M +$3.84M $6.75 36
2021 Q3 6.31M $43.7M -$8.6M $6.92 36
2021 Q2 7.11M $69.3M -$22.9M $9.74 38
2021 Q1 8.53M $134M -$11.6M $15.74 49
2020 Q4 8.78M $212M -$5.83M $24.21 48
2020 Q3 9.28M $156M +$91.8M $16.83 44
2020 Q2 3.7M $108M +$108M $29.32 31